Tag: biosimilar production challenges
Manufacturing Challenges for Biosimilars: Complex Production and Why It’s Not Like Generic Drugs
- By : Tamsin Riverton
- Date : Dec 22 2025
Biosimilars aren't simple copies like generics-they're complex biologics made in living cells. This article breaks down the real manufacturing challenges: glycosylation, scale-up, cold chain risks, regulatory hurdles, and how new tech is helping manufacturers keep up.
Popular Posts
Tags
generic drugs
medication safety
bioequivalence
online pharmacy
side effects
medication adherence
generic medications
telehealth prescription
drug side effects
ANDA approval
Hatch-Waxman Act
biosimilars
online pharmacy safety
brand vs generic
generic drug approval
FDA generics
fixed-dose combinations
ANDA process
medication errors
medication side effects